INSIGHTS ON CLINICAL TRIAL PARTNERING

• Why Early Medical Assessment Matters In Clinical Trials

  Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.

• How Do Site Payments Impact Clinical Trial Sustainability?

  Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

• Equitable Access To Clinical Trials & The Trial Modernization Act

  How are the Equitable Access to Clinical Trials (EACT) initiative and Clinical Trial Modernization Act (CTMA) being used to improve clinical trial inclusivity by addressing financial barriers?

• How State-Of-The-Art Clinical Trial Mobile Vision Clinics Work

  Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.

• Bridging The Engagement Gap In Obesity Trials

  2/13/2026

  Improve obesity trial retention with actionable guidance: provide proactive plateau counseling, simplify data capture, and leverage existing provider-patient relationships to sustain motivation.

• Outsourcing Patient Recruitment: What You Need To Know

  8/18/2025

  Sponsors and CROs are increasingly outsourcing patient recruitment to specialized vendors to address the ongoing challenge of meeting initial recruitment targets on time.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  4/3/2025

  In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.

• Metabolic Disorders Clinical Trial Case Study

  9/17/2024

  Check out this case study to learn how partnering with an accomplished contract research organization is essential in the complex and dynamic field of metabolic drug development.

• Medable Beats Forecasted FPI Date While Raising eCOA Adherence In Japan

  2/7/2025

  A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. See how they accomplished it and more with this case study.